On Friday shares of The Medicines Company (NASDAQ:MDCO) closed at $28.31. Company’s sales growth for last 5 years was 12.40% and EPS growth for next 5 years is recorded as 10.00%. On 10 April, The Medicines Company (NASDAQ:MDCO) announced preliminary revenue for the first quarter of 2015. The company expects net revenue in the range of $125 million to $130 million for Q1, a 29 to 26 percent decrease from the $177.2 million in 2014.
On last trading day Biogen Inc. (NASDAQ:BIIB) fell -0.23% to close at $425.65. Its volatility for the week is 2.51% while volatility for the month is 2.69%. BIIB’s sales growth for past 5 years was 17.30% and its EPS growth for past 5 years was 29.90%. Biogen Inc. (NASDAQ:BIIB) monthly performance is 4.30%. Biogen Inc. (NASDAQ:BIIB) announced it will report first quarter 2015 financial results on Friday, April 24, 2015, before the financial markets open.
On last trading day ArQule Inc. (NASDAQ:ARQL) remains unchanged to close at $2.16. Its volatility for the week is 4.36% while volatility for the month is 7.51%. ARQL’s sales growth for past 5 years was -14.80% and its EPS growth for past 5 years was 14.70%. ArQule Inc. (NASDAQ:ARQL) monthly performance is -8.86%. ArQule Inc. (NASDAQ:ARQL) announced that the Company will present at the 14th Annual Needham Healthcare Conference on Tuesday, April 14, 2015 at 3:00 p.m.
Mirati Therapeutics, Inc. (NASDAQ:MRTX) has 0.10% insider ownership while its institutional ownership stands at 59.30%. In last trading activity company’s stock closed at $27.42. Jefferies Group LLC began coverage on shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX) in a report released on Friday. The firm issued a buy rating and a $34.00 price objective on the stock.
Ford Motor Company (NYSE:F) has 0.10% insider ownership while its institutional ownership stands at 59.00%. In last trading activity company’s stock closed at $16.03. On 10 April, Ford Motor Company (NYSE:F) said it had taken control of its Russian venture with Russian car company Sollers and would provide it with additional financial support.